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Abstract
Introduction: Similar to pheochromocytomas, paragangliomas can secrete catecholamines, although they are
usually non-functional and clinical presentation is non-specific. We present a case of accidental, intra-operatively
diagnosed neuroendocrine-active sympathetic paraganglioma, which was suspected and confirmed during elective
retroperitoneal tumor removal.
Case presentation: A 25-year-old Caucasian Croatian man, American Society of Anesthesiologists status 1,
underwent elective surgery for retroperitoneal tumor removal. The tumor had been discovered by chance during a
routine examination and was suspected to be a sarcoma. Our patient had no history of previous medical conditions
nor did he have symptoms characteristic of a neuroendocrine secreting tumor. The results of ultrasound and
magnetic resonance imaging studies showed a large, well demarcated retroperitoneal tumor mass in his upper
abdomen localized between the aorta and vena cava, measuring approximately 9×6×4.5cm. In the operating room
an epidural catheter was inserted at the T7 to T8 level prior to induction of general anesthesia. Epidural analgesia
was maintained by an infusion pump with local anesthetic and opiate mixture. During the surgical excision of the
tumor, hemodynamic changes occurred, with hypertension (205/110mmHg) and tachycardia (up to 120 beats/
minute). In spite of the fact that the surgical field of work did not include adrenal glands whose direct
manipulation could explain this occurrence, there was a high degree of suspicion for the presence of a
neurosecreting tumor. His clinical symptoms were relieved after administration of urapidil, esmolol and magnesium
sulfate. After tumor excision, our patient developed severe hypotension. Hemodynamic stability was reinstated with
aggressive volume replacement, with crystalloids and colloids, vasopressors and hydrocortisone. His post-operative
course was unremarkable and on the eighth post-operative day our patient was discharged from hospital, with no
consequences or symptoms on follow-up two years after surgery.
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Conclusions: Our patient’s case emphasizes the need to consider the presence of extra-adrenal paragangliomas in
the differential diagnosis of retroperitoneal tumors, despite their rare occurrence. In our patient’s case, invasive
hemodynamic monitoring during combined general anesthesia and epidural analgesia and early recognition of
catechol-induced symptoms raised suspicion of the existence of a paraganglioma, and this led to an adequate
therapeutic approach and favorable outcome of the surgery. Pre-operative recognition of paragangliomas could
lead to better pre-operative preparation, but even high clinical suspicion in undiagnosed forms during surgery and
the availability of rapid and short-acting vasodilatators, α-blockers and β-blockers might favor good outcome.
Keywords: Epidural analgesia, Invasive hemodynamic monitoring, Paraganglioma/pheochromocytoma, Therapeutic
protocols
Introduction
Paragangliomas of the retroperitoneum are neuroendocrine
tumors arising from the sympathoadrenal paraganglial
autonomic nervous system. Most of the tumors arise in
the adrenal medulla as pheochromocytoma, also known as
intra-adrenal paraganglioma, while the remaining arise
in aortic-sympathetic extra-adrenal paraganglia along
the paravertebral axis as extra-adrenal sympathetic para-
gangliomas. Paragangliomas account for 15 percent to 20
percent of pheochromocytomas and have a high incidence
of malignancy (13 percent to 26 percent) [1-5]. Most
tumors are hormonally active (up to 60 percent) and cause
symptoms associated with the excessive secretion of
catecholamines. The most common symptoms include
hypertension associated with headache, sweating and
palpitations. Although paragangliomas are rare, the poten-
tial for release of catecholamines presents a significant clin-
ical hazard. In fact, great care must be exercised during
surgical removal of paragangliomas. Their excision is
considered extremely difficult due to their high vascularity
and adherence to multiple adjacent structures, including
the aorta, vena cava, and renal and mesenteric vessels. Re-
gardless, the risk of their malignant transformation justifies
aggressive management [6].
We present a case of accidental, intra-operatively diagnosed
functional extra-adrenal sympathetic paraganglioma in which
a high level of suspicion during a surgical procedure
performed using combined epidural analgesia and general
anesthesia resulted in optimal hemodynamic management
during surgery.
Case presentation
A 25-year-old Caucasian Croatian man, American Society
of Anesthesiologists (ASA) status 1, underwent elective sur-
gery for removal of a retroperitoneal tumor suspected to be
a sarcoma. The tumor had been discovered accidentally
during a routine examination. Our patient had no history
of previous medical conditions. His family history did not
suggest a hereditary disorder. He had no symptoms that
could be related to a neuroendocrine-secreting tumor such
as hypertension, palpitations, sweating, headache, glucose
intolerance or Cushing’s appearance. His height was
165cm, weight 55kg and body mass index (BMI) was
20.2kg/m2. Pre-operative laboratory findings, chest X-ray
and electrocardiogram (ECG) results were normal; his
blood pressure measured 120/70mmHg pre-operatively.
Ultrasound and magnetic resonance imaging (MRI) results
showed a large, well-demarcated retroperitoneal tumor
mass in his upper abdomen localized between the aorta
and vena cava, measuring approximately 9×6×4.5cm,
leaning on the liver and pancreas and spreading towards,
but not affecting, the right adrenal gland. Our patient
received midazolam 7.5mg orally 30 minutes before he was
taken to the operating room. After establishing intravenous
access and placing standard anesthesia monitors (non-inva-
sive measurement of blood pressure (NIBP), ECG, SpO2
(pulse oximetry), and temperature), an epidural catheter
was inserted in the epidural space between T7 and T8
under local anesthesia. Its correct epidural placement was
tested with 60mg of lidocaine (with no additional epineph-
rine) to exclude the possibility of intra-vascular or intra-
thecal puncture. A mixture of 0.25 percent levobupivacaine
25mg and sufentanil 10μg were administered epidurally
twice as a bolus dose to adjust the block level, before the in-
duction of general anesthesia. The epidural analgesia was
tested by loss of sensation to pinprick and cold, compared
to an unblocked dermatome. To eliminate surgical stress
during the resection in accordance with the localization of
tumor as assessed by MRI, the aiming level of epidural an-
algesia was adjusted to be from T5 to T12. Induction of
anesthesia was made with propofol 120mg, sufentanil 10μg,
following rocuronium 50mg to facilitate endotracheal
intubation. Our patient received an arterial line for invasive
blood measurement and a central venous catheter in
the right jugular vein for central venous pressure measure-
ment. The anesthesia was maintained with sevoflurane,
in a mixture of O2 and air (in 40:60 ratios). Epidural anal-
gesia was maintained continuously with an infusion pump
(mixture of 0.125 percent levobupivacaine 50mg with
sufentanil 10μg in 50mL of saline, infusion rate 5 to 25mL/
hour) and this block completely satisfied intra-operative
analgesic demands.
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During the surgical excision of the tumor, severe and
unexpected hemodynamic changes occurred. Minimal
tumor manipulation was followed with severe hyperten-
sion measuring 205/110mmHg and tachycardia up to 120
beats/minute. Due to the fact that the surgical manipula-
tion did not affect the adrenal glands and that epidural
anesthesia was tested as sufficient for the anticipated sur-
gery and also proven to be effective for treating surgical
stimuli until this change occurred, suspicion of the pres-
ence of a neurosecreting tumor was raised.
The levels of both anesthesia and analgesia were
increased in order to rule out too light a level of anesthesia
and, as a consequence, pain. A bolus dose of intravenous
sufentanil (25μg) was given, along with increase of the
sevoflurane minimum alveolar concentration (MAC) and
infusion rate of epidural analgesia (for 15 minutes), but the
hypertension and tachycardia could not be suppressed by
these pharmacological measures.
Also, we tried to rule out the other most common
causes of such hemodynamic changes. Based on our
patient’s medical history we could rule out pre-existing
cardiac conditions, autonomic nerve system dysfunctions
or hormonal disorders such as thyroid storm. His body
temperature did not rise so we ruled out the presence of
malignant hyperthermia. Basic laboratory results did not
suggest any severe electrolyte disorder. All the symptoms
were reflecting high and unsuppressed catecholamine ac-
tivity. The clinical symptoms diminished only after add-
itional administration of intravenous urapidil 40mg,
esmolol 20mg and MgSO4 (magnesium sulfate) 2g.
Due to a large intra-operative blood loss because of
the tumor’s extremely high vascularization our patient
received high volume replacement in the form of
crystalloids (7500mL), colloids (2000mL), and multiple
blood transfusions (red blood cells (RBC) 1400mL and
fresh frozen plasma (FFP) 1000mL). Adequate central
venous pressure and diuresis were maintained during
the procedure.
After excision of the tumor, our patient developed
hypotension, due to the ‘downregulation’ of the recep-
tors, with a lowest blood pressure measurement of 65/
35mmHg. The epidural infusion was immediately
discontinued. This condition was treated with additional
large volume replacement with crystalloids, colloids, and
vasopressors (norepinephrine up to 0.25μg/kg/min) in
order to achieve a mean arterial pressure (MAP) over
65mmHg. Additional hemodynamic stability was eventu-
ally restored after administration of a bolus dose of hydro-
cortisone 100mg intravenously, which eventually led to
cessation of the vasopressor infusion 45 minutes later.
His post-operative course was unremarkable. After the
surgery, our patient was admitted to our Intensive Care
Unit (ICU) where he remained intubated and ventilated
for two hours. He was hemodynamically stable, without
vasopressor support. There were no episodes of hyperten-
sion or tachycardia reported. Analgesia was supplied by
epidural catheter and our patient experienced no pain. He
was transferred to the ward the next day and on the eighth
post-operative day he was discharged from hospital. The
final pathology report confirmed the presence of an extra-
adrenal sympathetic paraganglioma (EASP).
Discussion
Extra-adrenal paragangliomas have the ability, similar to
pheochromocytomas, to be hormonally active. This onset
of activity can result in sudden, life-threatening cardiovas-
cular, neurological or metabolic crisis. A few patients
(13 percent) may be asymptomatic in spite of high levels
of circulating catecholamines due to receptor ‘down-
regulation’. The asymptomatic features make it difficult
for clinicians to detect the tumor at an early stage [7]. De-
tection is even more challenging for physicians working in
institutes that do not perform routine screening tests for
such malignancies. The greatest danger from this clinically
silent paraganglioma is hemodynamic instability when
they are being manipulated during surgery, leading to le-
thal complications and outcomes.
Therefore, when dealing with a patent with retroperi-
toneal tumor, it is crucial to consider the presence of a
hormonally active paraganglioma even in an asymptom-
atic patient.
A wide range of diagnoses should be considered in
order to plan the best treatment for the patient.
Grumbach et al. recommend the combination of
biochemical and imaging tests [8]. The biochemical diag-
nosis of hyper-functional paraganglioma (or adrenal
pheochromocytoma) is based on excessive excretion of
catecholamines and their metabolites. Determination of
24-h urinary excretion of total metanephrines and
catecholamines (norepinephrine, epinephrine, and dopa-
mine) has been widely used as a screening test panel [9].
With regard to imaging techniques, MRI is associated
with the lowest false negative localization rate, and radio-
active iodine-labeled metaiodobenzylguanidine (MIBG)
scintigraphy is the least sensitive imaging study of all.
Although lacking in sensitivity, MIBG scintigraphy is
highly specific and may be the only positive imaging test
result in some patients [10].
In our patient, a retroperitoneal tumor was mistaken
for a sarcoma on MRI findings, in spite of MRI’s
reported 91 percent sensitivity for extra-adrenal tumors
[11]. Due to the lack of pre-operative recognition, our
patient did not receive pharmacological pre-conditioning
with α-blockers and β-blockers prior to the procedure,
which led to hemodynamic instability intra-operatively.
As described, we established an adequate level and qual-
ity of epidural analgesia for the anticipated surgery,
which meant that pharmacological sympathectomy at
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the desired levels was also accomplished. The depth of
anesthesia at the moment of the removal of the tumor
was also sufficient so that the resulting extreme hyper-
tensive reaction and tachycardia had to be attributed to
the massive release of catecholamines in an intra-
abdominal localization.
Epidural analgesia is beneficial in patients who undergo
open procedures with a large incision for its anesthetic and
analgesic features intra-operatively and post-operatively. It
is recommended for abdominal pheochromocytoma (and
other neurosecreting tumor) resection in order to avoid the
marked fluctuation of blood pressure that may accompany
the induction of general anesthesia, and it also reduces the
need for vasoactive drugs in the anesthesia management
due to its sympathomimetic features [12,13]. It is an effect-
ive and safe method to prevent fluctuations in hormone
levels. This combination of epidural analgesia and general
anesthesia may not prevent hemodynamic fluctuations dur-
ing tumor manipulation, but appears to facilitate a rapid
and stable post-operative recovery [14].
Our patient’s hypertension was treated with urapidil intra-
operatively and esmolol was given to suppress tachycardia.
Additional hemodynamic control was obtained with slow in-
fusion of MgSO4 to a total dose of 2g. We administered
magnesium since it is widely reported in the anesthetic
management of pheochromocytoma crisis as a vasodilator.
The mechanism of magnesium’s action lies in its ability to
decrease catecholamine release. It is also a highly effective
α-adrenergic antagonist and anti-arrhythmic drug. Further-
more, magnesium appears to be predominantly an arteriolar
dilator, reducing peripheral resistance but with minimal ef-
fect on venous return and therefore maintaining cardiac
output. The ability of MgSO4 to control hemodynamic
disturbances in the presence of extremely large catechol-
amine concentrations was demonstrated by the high levels
of cardiovascular control obtained during surgery in our
patient’s case [15].
Conclusions
Undiagnosed functional paragangliomas carry high morbid-
ity and mortality rates and multiple pharmacotherapeutic
interventions have been proposed to minimize intra-
operative cardiovascular complications. Only a few cases
have been reported regarding management of accidental
intra-operatively diagnosed functional paragangliomas
where anesthesia was conducted via the combination of
epidural analgesia and general anesthesia.
This combination of epidural and general anesthesia
and the availability of rapid, short-acting vasodilatators
(urapidil, MgSO4) and β-blockers (esmolol) led to satis-
factory management of a pre-operatively undiagnosed
hormonally active tumor in our patient’s case.
It is important to have in mind the possible presence
of this usually clinically silent but still hormonally active
tumor when sudden unexplained hemodynamic instabil-
ity occurs intra-operatively. Also, it is important to sus-
pect and appropriately investigate the existence of
paragangliomas in every case of retroperitoneal tumor,
even in a hemodynamically stable and asymptomatic pa-
tient. A thorough differential diagnosis is essential in
order to plan the best treatment and therefore gain the
best outcome for the patient.
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